OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 123 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 1.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $1,514,000 | -62.8% | 717,500 | -12.8% | 0.01% | -60.0% |
Q2 2015 | $4,075,000 | -11.7% | 823,200 | +39.7% | 0.02% | -16.7% |
Q1 2015 | $4,613,000 | -25.7% | 589,100 | -42.5% | 0.02% | -18.2% |
Q4 2014 | $6,208,000 | +7.7% | 1,024,500 | -24.3% | 0.02% | +4.8% |
Q3 2014 | $5,763,000 | -14.5% | 1,352,900 | +24.0% | 0.02% | -8.7% |
Q2 2014 | $6,742,000 | +32.0% | 1,090,900 | +38.8% | 0.02% | +27.8% |
Q1 2014 | $5,109,000 | +9.9% | 786,000 | -4.8% | 0.02% | +5.9% |
Q4 2013 | $4,650,000 | – | 826,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management I, LLC | 1,229,287 | $9,625,000 | 44.28% |
Foresite Capital Management II, LLC | 4,200,047 | $32,886,000 | 19.48% |
Scale Management, LLC | 2,884,305 | $22,584,000 | 11.28% |
Cheyne Capital Management (UK) LLP | 1,484,409 | $11,601,000 | 2.80% |
Telemetry Investments, L.L.C. | 463,039 | $3,626,000 | 2.00% |
NEA Management Company, LLC | 3,709,000 | $29,041,000 | 1.31% |
Rock Springs Capital Management LP | 1,550,000 | $12,137,000 | 1.14% |
Rhenman & Partners Asset Management AB | 831,800 | $6,513,000 | 1.10% |
Tamarack Capital Management, LLC | 1,000,000 | $7,830,000 | 1.03% |
RA Capital Management | 1,186,229 | $9,288,000 | 0.92% |